Jonathan S Jaffe

Biography

  Jaffe joined Antares Pharma in July 2012 as Vice President of Clinical Development. Immediately prior to joining Antares, Dr Jaffe served on a consulting basis for Pharmanet-i3 as a clinical program leader in inflammatory bowel disease in Pfizer’s Bio-therapeutics Unit. Prior to working at Pharmanet-i3, Dr. Jaffe led global clinical development programs, conducting all phases of research, for respiratory, transplant and autoimmune indications at Schering Plough Research Institute, Novartis, and Forest Research Institute. Dr. Jaffe received a Bachelor of Arts degree in Biology from Lehigh University and an MD from the Jefferson Medical College of Thomas Jefferson University in Philadelphia. He completed a residency in Internal Medicine at Lenox Hill Hospital, followed by clinical and laboratory fellowships at the Laboratory of Clinical Investigation, NIAID, NIH, while in the Research Officers Group of the Public Health Service. Following fellowship, Dr Jaffe served on the full-time academic faculty of Hahnemann (now Drexel) University Medical School where he conducted research, taught in the clinics and provided medical care. His work on clinical development programs has resulted or contributed to multiple regulatory approvals of compounds both in the US and abroad including Rapamune, Remicade, Xolair, Zortress, and Daliresp.

Research Interest